Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
The highest dose group achieved average reductions of around 20% of body weight
Pentadecapeptide Gastric protein fragment A 15-amino-acid synthetic peptide from a partial sequence of human gastric juice protein
UV-Response & Pigmentation-Adaptation Research UV-response and pigmentation-related signaling pathways Amount: 250500mcg Frequency: 23 times weekly Duration: 68 weeks Research Notes Pigmentation-related observations may gradually increase over time depending on UV exposure and individual variability
Improved Appetite Control: By supporting appetite regulation, GLP-1 therapy helps reduce cravings and encourages consistent nutritional habits
[Diastolic murmur caused by a phaeochromocytoma (author's transl)]
Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat
US$ 28.42
US$ 23.15
US$ 27.36
US$ 29.29
